Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stephenson

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Nature Medicine|October 8, 2021
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trialKathryn E Stephenson, Boris Julg, C Sabrina Tan, et al.
Cell Host & Microbe|August 16, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.
Cell Host & Microbe|January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.
JAMA|March 11, 2021
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19Kathryn E Stephenson, Mathieu Le Gars, Jerald Sadoff, et al.
Journal of the National Cancer Institute|August 21, 2003
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal womenT J Key, P N Appleby, G K Reeves, et al.
Lancet (London, England)|July 27, 2018
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H Barouch, Frank L Tomaka, Frank Wegmann, et al.
Science Translational Medicine|July 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trialK Rachael Parks, Zoe Moodie, Mary A Allen, et al.
Nature Medicine|February 5, 2020
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donorVincent Dussupt, Rajeshwer S Sankhala, Gregory D Gromowski, et al.
Physical Review Letters|July 22, 2017
Phase Locking the Spin Precession in a Storage RingN Hempelmann, V Hejny, J Pretz, et al.
Physical Review Letters|September 16, 2015
New Method for a Continuous Determination of the Spin Tune in Storage Rings and Implications for Precision ExperimentsD Eversmann, V Hejny, F Hinder, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Nature Medicine|October 8, 2021
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trialKathryn E Stephenson, Boris Julg, C Sabrina Tan, et al.
Cell Host & Microbe|August 16, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.
Cell Host & Microbe|January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.
JAMA|March 11, 2021
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19Kathryn E Stephenson, Mathieu Le Gars, Jerald Sadoff, et al.
Journal of the National Cancer Institute|August 21, 2003
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal womenT J Key, P N Appleby, G K Reeves, et al.
Lancet (London, England)|July 27, 2018
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H Barouch, Frank L Tomaka, Frank Wegmann, et al.
Science Translational Medicine|July 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trialK Rachael Parks, Zoe Moodie, Mary A Allen, et al.
Nature Medicine|February 5, 2020
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donorVincent Dussupt, Rajeshwer S Sankhala, Gregory D Gromowski, et al.
Physical Review Letters|July 22, 2017
Phase Locking the Spin Precession in a Storage RingN Hempelmann, V Hejny, J Pretz, et al.
Physical Review Letters|September 16, 2015
New Method for a Continuous Determination of the Spin Tune in Storage Rings and Implications for Precision ExperimentsD Eversmann, V Hejny, F Hinder, et al.
Pageof 25